These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 5396909)

  • 1. [Clinical biochemistry of gout].
    Greiling H
    Dtsch Med J; 1969 May; 20(10):336-41. PubMed ID: 5396909
    [No Abstract]   [Full Text] [Related]  

  • 2. Accelerated erythrocyte 5-phosphoribosyl-1-pyrophosphate synthesis. A familial abnormality associated with excessive uric acid production and gout.
    Sperling O; Eilam G; Sara-Persky-Brosh ; De Vries A
    Biochem Med; 1972 Aug; 6(4):310-6. PubMed ID: 4340256
    [No Abstract]   [Full Text] [Related]  

  • 3. Purine base incorporation into erythrocyte nucleotides and erythrocyte phosphoribosyltransferase activity in primary gout.
    Sperling O; Ophir R; de Vries A
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):147-51. PubMed ID: 5552535
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout.
    Kelley WN; Greene ML; Rosenbloom FM; Henderson JF; Seegmiller JE
    Ann Intern Med; 1969 Jan; 70(1):155-206. PubMed ID: 4884382
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and biological aspects of dyspurinia with enzyme deficiency].
    Kaplan G
    Pathol Biol (Paris); 1970 Oct; 18(19):881-6. PubMed ID: 4922808
    [No Abstract]   [Full Text] [Related]  

  • 6. Concentration and synthesis of phosphoribosylpyrophosphate in erythrocytes from normal, hyperuricemic, and gouty subjects.
    Meyskens FL; Williams HE
    Metabolism; 1971 Aug; 20(8):731-42. PubMed ID: 4327978
    [No Abstract]   [Full Text] [Related]  

  • 7. A new assay method for hypoxanthine-guanine phosphoribosyltransferase.
    Chow DC; Kawahara FS; Saunders T; Sorensen LB
    J Lab Clin Med; 1970 Nov; 76(5):733-8. PubMed ID: 5477333
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidemiology and biochemistry of risk factors of gout (author's transl)].
    Mertz DP
    MMW Munch Med Wochenschr; 1974 Feb; 116(8):349-56. PubMed ID: 4208091
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic defects of primary hyperuricemia and gout.
    Wyngaarden JB
    Am J Med; 1974 May; 56(5):651-64. PubMed ID: 4363475
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current biochemical acquisitions on pathogenesis of gout].
    Marcolongo R
    Reumatismo; 1971; 23(3):109-25. PubMed ID: 5150688
    [No Abstract]   [Full Text] [Related]  

  • 11. The Jewish Hospital of St. Louis. Therapeutic grand rounds number 7. An approach to disorders of uric acid metabolism.
    Thier SO; Wessler S; Avioli LV
    Arch Intern Med; 1974 Sep; 134(3):579-85. PubMed ID: 4855167
    [No Abstract]   [Full Text] [Related]  

  • 12. Nyhan-Lesch syndrome and juvenile gout (2 cases).
    Bluestone R
    Proc R Soc Med; 1968 Nov; 61(11 Part 1):1119-20. PubMed ID: 5722547
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypoxanthine-guanine phosphoribosyltransferase deficiency in the Lesch-Nyhan syndrome and gout.
    Kelley WN
    Fed Proc; 1968; 27(4):1047-52. PubMed ID: 5658470
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased PP-ribose-P synthetase activity: a genetic abnormality leading to excessive purine production and gout.
    Becker MA; Meyer LJ; Kostel PJ; Seegmiller JE
    Adv Exp Med Biol; 1973; 41():307-15. PubMed ID: 4364688
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible functions of hypoxanthine-guanine phosphoribosyltransferase and their relation to the biochemical pathology of the Lesch-Nyhan syndrome.
    Henderson JF
    Fed Proc; 1968; 27(4):1075-7. PubMed ID: 4298064
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enzymopathic gout. Dyspurinia due to hypoxanthine-guanine-phosphoribosyl-transferase deficiency. Occurrence and clinical characteristics of enzyme repression].
    Delbarre F; Cartier P; Auscher C; de Géry A; Hamet M
    Presse Med (1893); 1970 Mar; 78(16):729-34. PubMed ID: 5445912
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenesis of gout].
    Strohmeyer G
    Internist (Berl); 1969 Jul; 10(7):284-5. PubMed ID: 4903707
    [No Abstract]   [Full Text] [Related]  

  • 18. Selected aspects of the aetiology, pathogenesis and treatment of disorders of purine metabolism.
    Boyle JA; Seegmiller JE
    Mod Trends Rheumatol; 1971; 2():299-322. PubMed ID: 4949589
    [No Abstract]   [Full Text] [Related]  

  • 19. Partial deficiency of hypoxanthine-guanine phosphoribosyltransferase associated with gout and uric acid lithiasis.
    Sperling O; Frank M; Ophir R; Liberman UA; Adam A; de Vries A
    Rev Eur Etud Clin Biol; 1970 Nov; 15(9):942-7. PubMed ID: 5505084
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)].
    Delbarre F; Auscher C; de Gery A; Brouilhet H; Olivier JL
    Presse Med (1893); 1968 Dec; 76(49):2329. PubMed ID: 5737251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.